Orbifloxacin, Mometasone, Posaconazole
315 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
315
Total Reports
4
Deaths Reported
130.0%
Death Rate
Active Ingredients
Orbifloxacin, Mometasone, Posaconazole
Administration Routes
Auricular (Otic)TopicalUnknownOralOphthalmicIntraocular
Species Affected
Dog 265
Unknown 32
Cat 15
Human 2
Macaw 1
Most Affected Breeds
Unknown 35
Crossbred Canine/dog 34
Retriever - Labrador 28
Shih Tzu 11
Domestic (unspecified) 10
Pug 10
Poodle (unspecified) 9
Boxer (German Boxer) 9
Retriever - Golden 8
Shepherd Dog - German 8
Most Reported Reactions
Deafness 93
Partial deafness 67
Lack of efficacy - NOS 23
Vomiting 17
Missing Cap 16
Anorexia 14
Depression 14
Lack of efficacy (bacteria) - NOS 11
Diarrhoea 11
Accidental exposure 10
Other ear disorder NOS 9
Ataxia 8
Outcome Breakdown
Outcome Unknown
18 (33.3%)
Recovered with Sequela
12 (22.2%)
Ongoing
11 (20.4%)
Recovered/Normal
9 (16.7%)
Died
4 (7.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.